Related Experiment Video
Updated: Aug 9, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D
C González-Rubio1, R González-Muñiz, M A Jiménez-Clavero
1Unidad de Inmunología, Hospital La Paz, Madrid, Spain.
Factor J (FJ), a complement pathway inhibitor, was investigated for its effect on factor D activity. Studies confirmed that Factor J does not inhibit the proteolytic activity of factor D.
Area of Science:
- Immunology
- Biochemistry
- Complement System
Background:
- Factor J (FJ) is recognized as an inhibitor of both the classical and alternative complement pathways.
- FJ disrupts complement component C1 in the classical pathway and the C3 convertase (C3b,Bb) in the alternative pathway through direct interactions.
Purpose of the Study:
- To investigate the potential inhibitory effect of Factor J on the proteolytic activity of factor D.
- To clarify previous findings that could not definitively rule out an interaction between Factor J and factor D.
Main Methods:
- Enzymatic activity of serine proteinase factor D was assessed using two specific peptide thioester substrates.
- Reactivity assays were conducted both in the presence and absence of Factor J.
- Kinetic studies were performed to analyze the interaction.
Main Results:
- Kinetic analyses demonstrated that Factor J had no discernible effect on the enzymatic activity of factor D.
- Factor J did not alter the proteolytic function of factor D under the tested conditions.
Conclusions:
- Factor J does not inhibit the serine proteinase activity of factor D.
- This study clarifies the specific interactions within the complement system, indicating Factor J's role is not through factor D inhibition.
Related Concept Videos
Feedback Inhibition
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Overview
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Mechanism
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis

